Homyk
Homyk v. ChemoCentryx, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 JONNIE HOMYK, et al., Case No. 21-cv-03343-JST (LJC)
Plaintiffs,
ORDER DENYING RELIEF SOUGHT
v. BY LEAD PLAINTIFF IN JOINT
DISCOVERY LETTER BRIEF
CHEMOCENTRYX, INC., et al., Re: ECF No. 99 Defendants.
12 Before the Court is the parties’ Joint Discovery Letter Brief. ECF No. 99. Lead Plaintiff Indiana Public Retirement System seeks an order authorizing it to provide the U.S. Food and Drug Administration (FDA) with deposition exhibits and testimony marked as confidential pursuant to the Protective Order governing this case (ECF No. 69) by Defendants ChemoCentryx, Inc. (ChemoCentryx), and Thomas J. Schall, President and CEO of ChemoCentryx. Id. at 1. Lead Plaintiff contends that this disclosure and use of the material is necessary to allow the FDA to provide testimony by affidavit or sworn declaration. Id. The Court held a hearing on the matter on March 5, 2024. ECF No. 127. After the hearing, per the Court’s order, Lead Plaintiff filed…